Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
GHRH antagonists may hold promise for treatment of prostatic, mammary tumors
September 15th, 2005
Growth-hormone-releasing hormone (GHRH) antagonists may hold promise for the treatment of prostatic and mammary tumors. According to a study from Spain, "Growth-hormone-releasing hormone receptor (GHRH-R) mRNA [messenger ribonucleic acid] and protein was first localized to the anterior pituitary gland, consequent with the action of its ligand on GH synthesis and release. Subsequent studies found GHRH-R also expressed in the hypothalamus and in systemic tissues including those of the reproductive system." "In the present work, we studied the distribution of GHRH-R in human reproductive system of males and females by immunohistochemical method. GHRH-R...
Source: Women's Health Weekly (2005-09-15)
|
